Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed May 15, 2017 · 10-Q · 45 days after period end · 0001213900-17-005183
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$8.06M | -$4.40M | -$3.07M | -$16.70M |
| EPS Diluted | -$0.14 | -$0.10 | -$0.09 | -$0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end
